Spotlight -

Downstream Processing|

Upstream Processing

|Podcasts|April 26, 2018

Insights on Purity and Intactness of AAV Gene Therapy Vectors

Author(s)Vironova

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

Concept of treatment and adjustment of DNA | Image Credit: © natali_mis - © natali_mis - stock.adobe.com

Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms

ByFeliza Mirasol

October 7th 2025

Human head | Image Credit: © ShpilbergStudios - © ShpilbergStudios - stock.adobe.com

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

ByFeliza Mirasol

October 7th 2025

DNA double helix under a magnifying glass, symbolizing genetic engineering and gene manipulation. CRISPR technology, genome editing, molecular biotechnology, genetic science research, gene therapy. 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

IDT Debuts Protein Solution to Improve CRISPR Knock-In Accuracy

ByFeliza Mirasol

September 25th 2025

Background with viruses. Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy. A model is built using data of viral macromolecular structure from Protein Data Bank (PDB 3NG9) | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com

AAV Manufacturing Partnership Supports Gene Therapy for CLN2 Batten Disease

ByFeliza Mirasol

September 4th 2025

Quality Control Laboratory medicine. Chromatograph operation. A woman makes an analysis on a gas chromatograph. Development of a new vaccine against the covid-19 virus. | Image Credit: © neznamov1984 - © neznamov1984 - stock.adobe.com

ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing

ByFeliza Mirasol

August 14th 2025

Trending on BioPharm International

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

© 2025 MJH Life Sciences^®

All rights reserved.